J. M. A. Lange

2.2k total citations · 1 hit paper
22 papers, 1.7k citations indexed

About

J. M. A. Lange is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, J. M. A. Lange has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Virology and 6 papers in Immunology. Recurrent topics in J. M. A. Lange's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). J. M. A. Lange is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). J. M. A. Lange collaborates with scholars based in Netherlands, France and Slovakia. J. M. A. Lange's co-authors include Jaap Goudsmit, Peter Reiß, Marianne Harris, Danielle M. Smith, Brian Conway, David B. Hall, Mark A. Wainberg, Patrick Robinson, Maureen Myers and Stefano Vella and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

J. M. A. Lange

22 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

1998 611 citations Julio Montaner, Peter Reiß et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. M. A. Lange Netherlands	14	1.3k	1.2k	343	184	154	22	1.7k
Leslie Jonas United States	10	1.7k 1.3×	1.7k 1.4×	486 1.4×	189 1.0×	234 1.5×	11	2.2k
Ruth Dickover United States	20	1.1k 0.8×	996 0.8×	483 1.4×	281 1.5×	146 0.9×	26	1.5k
Martin S. Hirsch United States	7	1.1k 0.8×	1.2k 1.0×	458 1.3×	95 0.5×	130 0.8×	7	1.6k
John Delehanty United States	11	1.1k 0.8×	1.2k 0.9×	232 0.7×	152 0.8×	75 0.5×	13	1.5k
Knut Lidman Sweden	22	1.1k 0.9×	1.1k 0.9×	475 1.4×	321 1.7×	141 0.9×	51	1.9k
J Aboulker France	23	1.1k 0.8×	1.1k 0.9×	435 1.3×	254 1.4×	338 2.2×	91	1.8k
Robert Yarchoan United States	16	787 0.6×	833 0.7×	428 1.2×	260 1.4×	104 0.7×	20	1.4k
Jean‐Louis Sankalé United States	14	1.2k 0.9×	1.0k 0.8×	443 1.3×	267 1.5×	90 0.6×	20	1.5k
Gail Skowron United States	19	693 0.5×	693 0.6×	332 1.0×	192 1.0×	158 1.0×	45	1.2k
E. Randall Lanier United States	24	1.4k 1.1×	1.3k 1.1×	512 1.5×	133 0.7×	263 1.7×	39	1.9k

Countries citing papers authored by J. M. A. Lange

Since Specialization

Citations

This map shows the geographic impact of J. M. A. Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. A. Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. A. Lange more than expected).

Fields of papers citing papers by J. M. A. Lange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. A. Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. A. Lange. The network helps show where J. M. A. Lange may publish in the future.

Co-authorship network of co-authors of J. M. A. Lange

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. A. Lange. A scholar is included among the top collaborators of J. M. A. Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. A. Lange. J. M. A. Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tierney, William M., et al.. (2022). User-Centered Design of a Clinical Tool for Shared Decision-making About Diet in Primary Care. Journal of General Internal Medicine. 38(3). 715–726. 1 indexed citations

Neal, Maxwell L., Andrew D. Trister, Sunyoung Ahn, et al.. (2013). Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression. Cancer Research. 73(10). 2976–2986. 49 indexed citations

Clevenbergh, Philippe, et al.. (2006). Database-Supported Teleconferencing: An Additional Clinical Mentoring Tool to Assist a Multinational Company HIV/AIDS Treatment Program in Africa. HIV Clinical Trials. 7(5). 255–262. 10 indexed citations

Koot, M., R. E. Y. de Goede, Ireneus P.M. Keet, et al.. (1999). Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis. The Journal of Infectious Diseases. 179(1). 254–258. 82 indexed citations

Brinkman, Kees, Jan M. Prins, Suzanne Jurriaans, & J. M. A. Lange. (1999). [Primary HIV-infection: infectious mononucleosis-like presentation with treatment options].. PubMed. 143(22). 1129–33. 1 indexed citations

Montaner, Julio, Peter Reiß, David A. Cooper, et al.. (1998). A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients. JAMA. 279(12). 930–930. 611 indexed citations breakdown →

Katabira, Elly, Nelson K. Sewankambo, Roy D. Mugerwa, et al.. (1998). Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.. Sexually Transmitted Infections. 74(4). 265–270. 14 indexed citations

Leeuwen, Remko van, et al.. (1997). Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.. PubMed. 2(2). 79–90. 6 indexed citations

Veenstra, Jan A., Paul J. Veugelers, Ireneus P.M. Keet, et al.. (1997). Rapid Disease Progression in Human Immunodeficiency Virus Type 1--Infected Individuals with Adverse Reactions to Trimethoprim-Sulfamethoxazole Prophylaxis. Clinical Infectious Diseases. 24(5). 936–941. 19 indexed citations

10.

Frissen, P. H. J., Marc van der Valk, Chris H.H. ten Napel, et al.. (1994). Zidovudine and Interferon- Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 169(6). 1351–1355. 28 indexed citations

11.

Boucher, Charles A., Remko van Leeuwen, Paul Kellam, et al.. (1993). Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates. Antimicrobial Agents and Chemotherapy. 37(7). 1525–1530. 47 indexed citations

12.

Mulder, Jan W., P. H. J. Frissen, Pieta Krijnen, et al.. (1992). Dehydroepiandrosterone as Predictor for Progression to AIDS in Asymptomatic Human Immunodeficiency Virus-Infected Men. The Journal of Infectious Diseases. 165(3). 413–418. 54 indexed citations

13.

Boucher, Charles A., E O'Sullivan, Jan W. Mulder, et al.. (1992). Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive Subjects. The Journal of Infectious Diseases. 165(1). 105–110. 301 indexed citations

14.

Gans, Jan de, Peter Portegies, Philip T. Reiss, et al.. (1992). Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.. PubMed. 5(2). 137–42. 16 indexed citations

15.

Reiss, Peter, F de Wolf, Carla Kuiken, et al.. (1991). Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.. PubMed. 4(2). 165–72. 17 indexed citations

16.

Mulder, Jan W., Pieta Krijnen, Jaap Goudsmit, et al.. (1990). HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.. Sexually Transmitted Infections. 66(3). 138–141. 3 indexed citations

17.

Goudsmit, Jaap, J. M. A. Lange, Linda Smit, et al.. (1988). Serodiagnostic profiles of HIV and HIV pathogenesis in vivo.. PubMed. 21(2). 71–81. 1 indexed citations

18.

Wolf, F. de, Jaap Goudsmit, Deborah A. Paul, et al.. (1987). Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.. BMJ. 295(6598). 569–572. 116 indexed citations

19.

Danner, S. A., A. Bakker, J. M. A. Lange, et al.. (1986). Gallium-67 lung scintigraphy in patients with acquired immune deficiency syndrome (AIDS).. PubMed. 68(5). 313–8. 3 indexed citations

20.

Lange, J. M. A., Deborah A. Paul, Han G. Huisman, et al.. (1986). Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.. BMJ. 293(6560). 1459–1462. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact